GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 174 filers reported holding GENMAB A/S in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $26,174,000 | -46.5% | 661,621 | -40.9% | 0.60% | -30.3% |
| Q3 2021 | $48,961,000 | -2.3% | 1,120,388 | -8.7% | 0.85% | +15.1% |
| Q2 2021 | $50,122,000 | +14.6% | 1,227,588 | -7.9% | 0.74% | +20.5% |
| Q1 2021 | $43,737,000 | +22.1% | 1,332,212 | +26.0% | 0.62% | -6.9% |
| Q2 2020 | $35,835,000 | +9.2% | 1,057,393 | -31.7% | 0.66% | -28.0% |
| Q1 2020 | $32,823,000 | +56.9% | 1,549,000 | +65.4% | 0.92% | +84.0% |
| Q4 2019 | $20,917,000 | -17.3% | 936,700 | -25.0% | 0.50% | -41.0% |
| Q3 2019 | $25,297,000 | – | 1,248,600 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |